Colorectal resection is associated with persistent proangiogenic plasma protein changes: Postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion

Annals of Surgery

Volumn 249, Issue 6, 2009, Pages 973-977

  Shantha Kumara, H M C ^a   Feingold, Daniel ^a   Kalady, Matthew ^b   Dujovny, Nadav ^c   Senagore, Anthony ^c   Hyman, Neil ^d   Cekic, Vesna ^a   Whelan, Richard L ^a,e  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Ferguson Clinic   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; VASCULOTROPIN; ANGPT1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; COLORECTAL SURGERY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR GROWTH; ADENOCARCINOMA; BLOOD; CELL MOTION; CELL PROLIFERATION; CLINICAL TRIAL; COHORT ANALYSIS; COLON RESECTION; COLORECTAL TUMOR; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CELL MOVEMENT; CELL PROLIFERATION; COHORT STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649204247     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181a6cd72     Document Type: Article

References (19)

1. Delgado S, Lacy AM, Filella X, et al. Acute phase response in laparoscopic and open colectomy in colon cancer. Dis Colon Rectum. 2001;44:638-646.
2. Schwenk W, Jacobi C, Mansmann U, et al. Inflammatory response after laparoscopic and conventional colorectal resections. Langenbeck's Arch Surg. 2000;385:2-9.
3. Kirman I, Cekic V, Poltoratskaia N, et al. Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery. Surg Endosc. 2005;19:55-59.
4. Kirman I, Jain S, Cekic V, et al. Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer. Surg Endosc. 2006;20:482-486.
5. Belizon A, Balik E, Feingold DL. Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg. 2006;244:792-798.
6. Kumara S, Hoffman A, Nasar A, et al. Colorectal resection, open more so than minimally invasive in patients with benign indications is associated with proangiogenic changes in the plasma levels of angiopoietin 1 and 2. Surg Endosc. 2007;21:S352-S482.
7. Liekens S, DeClercq E, Neyts J. Angiogenesis: regulators and clinical applications [commentary]. Biochem Pharmacol. 2001;61:253-270.
8. Mels AK, Statius Muller MG, van Leeuwen PA, et al. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma. Br J Surg. 2001;88:539-544.
9. Belizon A, Horst P, Balik E, et al. Persistent elevation of plasma VEGF levels during the first month following minimally invasive colorectal resection. Surg Endosc. 2008;22:287-297.
10. Munro BZ. Statistical Methods for Health Care Research. 4th ed. Philadelphia, PA: Lippincott; 2001:68-69.
11. Takeda A, Shimada H, Imaseki H, et al. Clinical significance of serum endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers. Oncol Rep. 2000;7:333-338.
12. Kumar H, Heer K, Lee PW, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res. 1998;4:1279-1285.
13. Werther K, Christensen IJ, Nielsen HJ, et al. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer. 2002;86:417-423.
14. Tait CR, Jones PF. Angiopoetins in tumors: the angiogenic switch. J Pathol. 2004;204:1-10.
15. Gudehithlu KP, Ahmed N, Wu H, et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J Lab Clin Med. 2005;145:194-203.
16. Karayiannakis AJ, Zbar A, Polychronidis A, et al. Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur Surg Res. 2003;35:492-496.
17. Hormbrey E, Han C, Roberts A, et al. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332-4339.
18. Folkman J. Addressing tumor blood vessels. Nat Biotechnol. 1997;15:510.
19. Kirman I, Belizon A, Balik E, et al. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery. Eur J Surg Oncol. 2007;33:1169-1176.